In cancer cells, there is up-regulation of the PKM2 isoform, which has reduced activity compared to the PKM1 isoform and allows the accumulation of intermediates that can be used for neoplastic tissue growth via the pentose phosphate pathway [29,30,31]. Here, PKM is linked to cancer.